EFFECTS OF INTERMITTENT TREATMENT WITH ASPIRIN ON THROMBOXANE AND PROSTACYCLIN FORMATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
- 1 July 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 332 (8605), 245-247
- https://doi.org/10.1016/s0140-6736(88)92537-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.Heart, 1986
- Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death.Circulation, 1986
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditionsProstaglandins, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Inhibition of platelet prostaglandin synthetase by oral aspirin.JCI Insight, 1978
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- Acetylation of prostaglandin synthase by aspirin.Proceedings of the National Academy of Sciences, 1975
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975
- Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet AggregationProceedings of the National Academy of Sciences, 1974